Unknown

Dataset Information

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.


ABSTRACT: Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.

SUBMITTER: Mazumdar A 

PROVIDER: S-EPMC9762336 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature